SCHEMBL26537662

SCHEMBL26537662

COc1ccc(CN2C(=O)CCNC2=O)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
KDM1A O60341 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
TSHR P16473 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23120457 0.87 ALDH1A1 (0.49) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL23120576 0.79 MEN1 (0.61) GAAALDH1A1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL30616170 0.78 MEN1 (0.59) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL26116014 0.74 GAA (0.38) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL3124223 0.72 CASP3 (0.56) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4154483 0.72 APLNR (0.54) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL26641501 0.71 GSK3A (0.57) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL17696097 0.71 HTR3E (0.57) MEN1KMT2AHTR3EHTR3BHTR3A
SCHEMBL27396041 0.70 APLNR (0.51) GAAALDH1A1MEN1KMT2AMAPT
SCHEMBL1690285 0.68 HTT (0.46) GAAALDH1A1MEN1KMT2AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787785-B2 Pyrazolopyridine derivatives and uses thereof NOVARTIS AG (CH) 2023-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787785-B2 Pyrazolopyridine derivatives and uses thereof HBZ, ZFX, WIZ GAA 1170/4885ALDH1A1 1243/4885MEN1 4869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.